Skip to content
Clinical Trials – home
Verifiedinfo

Clinical Studies Pankow

Germany Breite Straße 20b, 13187 Berlin, Germany

  • 3 trials recruiting
  • Chronic obstructive pulmonary disease · Asthma
  • Adults and children

About Specializations

Clinical Studies Pankow in Berlin, Germany specialises in clinical trials of conditions such as Chronic obstructive pulmonary disease, Asthma, and other specialisations. This site conducts important research.

Main research areas of the site

Respiratory Medicine

The medical center is at the forefront of respiratory medicine, focusing on innovative treatments for Chronic Obstructive Pulmonary Disease (COPD). Through cutting-edge research, the center aims to improve patient outcomes and quality of life.

  • Chronic Obstructive Pulmonary Disease (COPD)
  • Astegolimab Efficacy and Safety
  • Acute Exacerbations Management

By evaluating the effects of astegolimab compared to placebo, the center contributes significantly to understanding and managing moderate and severe acute exacerbations of COPD, enhancing therapeutic strategies over a 52-week treatment period.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Breite Straße 20b13187 BerlinGermany
Recruiting now
3 trials
Conditions studied
2
Partner status
Verified

More sites in BerlinGermany

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

9 clinical trials

Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:LUNSEKIMIG
  • Sponsor:Sanofi-Aventis Recherche & Developpement
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Budesonide
  • Sponsor:AstraZeneca AB
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Beclometasone Dipropionate
  • Sponsor:Chiesi Farmaceutici S.p.A.
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Sponsor:Genentech Inc.
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Benralizumab
  • Sponsor:AstraZeneca AB
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Salbutamol
  • Sponsor:AstraZeneca AB
Countries:GermanyGermany
  • Participants:18–64 years
  • Substances:(2R)-N-[3-(5-Fluoro-2-{[2-Fluoro-3-(Methylsulfonyl)Phenyl]Amino}-4-Pyrimidinyl)-1H-Indol-7-Yl]-3-Methoxy-2-(4-Methyl-1-Piperazinyl)Propanamide-1-Hydroxy-2-Naphthoic Acid
  • Sponsor:AstraZeneca AB
Countries:GermanyGermany
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Budesonide
  • Sponsor:AstraZeneca AB
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.